Categories AlphaGraphs, Health Care
PFE Earnings: All you need to know about Pfizer’s Q4 2021 earnings results
Pfizer Inc. (NYSE: PFE) reported fourth quarter 2021 earnings results today.
Revenues doubled year-over-year to $23.8 billion. Excluding contributions from Comirnaty and Paxlovid, revenues dropped 2% operationally, driven mainly by the impact of fewer selling days compared to the prior-year quarter.
On a reported basis, net income jumped to $3.3 billion, or $0.59 per share, from $847 million, or $0.15 per share, last year. Adjusted net income more than doubled to $6.2 billion, or $1.08 per share, versus last year.
For full-year 2022, revenues are expected to range between $98-102 billion while adjusted EPS is estimated to range between $6.35-6.55.
Prior performance
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
MU Earnings: Micron’s Q4 profit declines but beats estimates
Micron Technology Inc. (NASDAQ: MU) Thursday said its fourth-quarter profit declined from last year, hurt by a sharp fall in revenues. Earnings, however, beat the market’s projection. On an adjusted
What are Philip Morris’ (PM) anticipations for the near term?
Shares of Philip Morris International Inc. (NYSE: PM) were down 1% on Thursday. The stock has dropped over 9% year-to-date. Although the tobacco industry has felt the pinch of inflation,
Key highlights from CarMax (KMX) Q2 2023 earnings results
CarMax, Inc. (NYSE:KMX) reported second quarter 2023 earnings results today. Net revenues rose 2% year-over-year to $8.1 billion. Net earnings were $125.9 million, or $0.79 per share, compared to $285.2 million,
